Antidepressants, benzodiazepines and azapirones for panic disorder in adults: a network meta-analysis

Giuseppe Guaiana; Corrado Barbui; Deborah M. Caldwell; Simon J.C. Davies; Toshi A. Furukawa; Hissei Imai; Markus Koesters; Aran Tajika; Irene Bighelli; Alessandro Pompoli; Andrea Cipriani

doi:10.1002/14651858.CD012729

Antidepressants, benzodiazepines and azapirones for panic disorder in adults: a network meta-analysis

Giuseppe Guaiana^*, Corrado Barbui, Deborah M. Caldwell, Simon J.C. Davies, Toshi A. Furukawa, Hissei Imai, Markus Koesters, Aran Tajika, Irene Bighelli, Alessandro Pompoli, Andrea Cipriani

^*Corresponding author for this work

Research output: Contribution to journal › Article (Academic Journal) › peer-review

12 Citations (Scopus)

485 Downloads (Pure)

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare individual active drugs (antidepressants, benzodiazepines and azapirones) and placebo in terms of efficacy and acceptability in the acute treatment of panic disorder, with or without agoraphobia. To rank treatments for panic disorder (antidepressants, benzodiazepines, azapirones and placebo) according to their effectiveness and acceptability.

Original language	English
Article number	CD012729
Number of pages	21
Journal	Cochrane Database of Systematic Reviews
Volume	2017
Issue number	7
DOIs	https://doi.org/10.1002/14651858.CD012729
Publication status	Published - 31 Jul 2017

Access to Document

10.1002/14651858.CD012729

Full-text PDF (final published version)
This is the final published version of the article (version of record). It first appeared online via Cochrane Library at https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012729/full . Please refer to any applicable terms of use of the publisher.
Final published version, 297 KB

Handle.net

Persistent link

Cite this

Guaiana, G., Barbui, C., Caldwell, D. M., Davies, S. J. C., Furukawa, T. A., Imai, H., Koesters, M., Tajika, A., Bighelli, I., Pompoli, A., & Cipriani, A. (2017). Antidepressants, benzodiazepines and azapirones for panic disorder in adults: a network meta-analysis. Cochrane Database of Systematic Reviews, 2017(7), Article CD012729. https://doi.org/10.1002/14651858.CD012729

@article{28d6169a83df4f55a58653a57a672887,

title = "Antidepressants, benzodiazepines and azapirones for panic disorder in adults: a network meta-analysis",

abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare individual active drugs (antidepressants, benzodiazepines and azapirones) and placebo in terms of efficacy and acceptability in the acute treatment of panic disorder, with or without agoraphobia. To rank treatments for panic disorder (antidepressants, benzodiazepines, azapirones and placebo) according to their effectiveness and acceptability.",

author = "Giuseppe Guaiana and Corrado Barbui and Caldwell, {Deborah M.} and Davies, {Simon J.C.} and Furukawa, {Toshi A.} and Hissei Imai and Markus Koesters and Aran Tajika and Irene Bighelli and Alessandro Pompoli and Andrea Cipriani",

year = "2017",

month = jul,

day = "31",

doi = "10.1002/14651858.CD012729",

language = "English",

volume = "2017",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "Cochrane Collaboration",

number = "7",

}

TY - JOUR

T1 - Antidepressants, benzodiazepines and azapirones for panic disorder in adults

T2 - a network meta-analysis

AU - Guaiana, Giuseppe

AU - Barbui, Corrado

AU - Caldwell, Deborah M.

AU - Davies, Simon J.C.

AU - Furukawa, Toshi A.

AU - Imai, Hissei

AU - Koesters, Markus

AU - Tajika, Aran

AU - Bighelli, Irene

AU - Pompoli, Alessandro

AU - Cipriani, Andrea

PY - 2017/7/31

Y1 - 2017/7/31

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare individual active drugs (antidepressants, benzodiazepines and azapirones) and placebo in terms of efficacy and acceptability in the acute treatment of panic disorder, with or without agoraphobia. To rank treatments for panic disorder (antidepressants, benzodiazepines, azapirones and placebo) according to their effectiveness and acceptability.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare individual active drugs (antidepressants, benzodiazepines and azapirones) and placebo in terms of efficacy and acceptability in the acute treatment of panic disorder, with or without agoraphobia. To rank treatments for panic disorder (antidepressants, benzodiazepines, azapirones and placebo) according to their effectiveness and acceptability.

UR - http://www.scopus.com/inward/record.url?scp=85026526480&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD012729

DO - 10.1002/14651858.CD012729

M3 - Article (Academic Journal)

AN - SCOPUS:85026526480

SN - 1469-493X

VL - 2017

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 7

M1 - CD012729

ER -

Antidepressants, benzodiazepines and azapirones for panic disorder in adults: a network meta-analysis

Abstract

Access to Document

Handle.net

Other files and links

Fingerprint

Research Fellowship

Cite this

Antidepressants, benzodiazepines and azapirones for panic disorder in adults: a network meta-analysis

Abstract

Access to Document

Handle.net

Other files and links

Fingerprint

Projects

Research Fellowship

Cite this